EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer

Chuan-Hao Zhang, Zhi-Liang Jiang, Yuan Meng, Wen-Yan Yang, Xin-Yu Zhang, Yan-Xia Zhang, Saadullah Khattak, Xin-Ying Ji, Dong-Dong Wu

Cellular Signalling · 2023

DOI: 10.1016/j.cellsig.2023.110628 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2023. Verfasst von Chuan-Hao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan 475004, China…. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Liver Neoplasms, Carcinoma, Hepatocellular, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is the sixth most frequent human cancer and the world's third most significant cause of cancer mortality. HCC treatment has recently improved, but its mortality continues to increase worldwide due to its extremely complicated and heterogeneous genetic abnormalities. After nitric oxide (NO) and carbon monoxide (CO), the third gas signaling molecule discovered is hydrogen sulfide (H2S), which has long been thought to be a toxic gas. However, numerous studies have proven that H2S plays many pathophysiological roles in mammals. Endogenous or exogenous H2S can decrease cell proliferation, promote apoptosis, block cell cycle, invasion and migration through various cellular signaling pathways. This review analyzes and discusses the recent literature on the function and molecular mechanism of H2S and H2S donors in HCC, so as to provide convenience for the scientific research and clinical application of H2S in the treatment of liver cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydrogen SulfideLiver NeoplasmsCarcinoma, HepatocellularAntineoplastic AgentsAnimalsHumansSignal TransductionNitric OxideMammals

Stichwörter der Autor:innen

Hepatocellular carcinomaHydrogen sulfideHydrogen sulfide donorsSignaling pathway

Substanzen

Hydrogen SulfideNitric OxideAntineoplastic Agents

Autor:innen und Institutionen

  • Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan 475004, China; School of Clinical Medicine, Henan University, Kaifeng, Henan 475004…
  • School of Clinical Medicine, Henan University, Kaifeng, Henan 475004, China.
  • Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan 475004, China.
  • Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan 475004, China. Electronic address: 10190096@vip.henu.edu.cn.
  • Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan 475004, China; School of Stomatology, Henan University, Kaifeng, Henan 475004, Chin…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, C. H., Jiang, Z. L., Meng, Y., Yang, W. Y., Zhang, X. Y., Zhang, Y. X., Khattak, S., Ji, X. Y., & Wu, D. D. (2023). Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2023.110628

Vancouver

Zhang CH, Jiang ZL, Meng Y, Yang WY, Zhang XY, Zhang YX, et al. Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer. Cellular Signalling. 2023. doi:10.1016/j.cellsig.2023.110628

BibTeX
@article{Zhang2023,
  author = {Zhang, Chuan-Hao and Jiang, Zhi-Liang and Meng, Yuan and Yang, Wen-Yan and Zhang, Xin-Yu and Zhang, Yan-Xia and Khattak, Saadullah and Ji, Xin-Ying and Wu, Dong-Dong},
  title = {Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer},
  journal = {Cellular Signalling},
  year = {2023},
  doi = {10.1016/j.cellsig.2023.110628}
}
Kostenlos starten →